The documents filed by Alexion with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov. These documents may also be obtained free of charge on Alexion’s internet website at

Most Recent SEC Filings · SEC Form 10-K · SEC Form 10-Q Alexion Pharmaceuticals (ALXN), Morning, 1.27, MCBC (MCFT), Afternoon, 0.33. American Axle

Alexion Provides Update on Form 10-Q Filing. Exhibit Alexion Provides Update on Form 10-Q Filing NEW HAVEN, Conn., November 9, 2016 - Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification of Late Filing with regard to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2016. The documents filed by Alexion with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov. These documents may also be obtained free of charge on Alexion’s internet website at Washington D.C., July 2, 2020 —. The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA).

Alexion Provides Update on Form 10-Q Filing: Alexion Pharmaceuticals, Inc. today announced that it has filed with the U.S. Securities and Exchange Co ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings) IRS No.: 133648318 | State of Incorp.:DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) announced today that they have entered into a In the quarterly investor filing with the SEC Wednesday, Alexion said the deal to end the investigation is not yet final. "While we have reached an agreement in principle with the SEC, SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 2021-04-09 · Alexion Pharmaceuticals, Inc. Common Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with the SEC. SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 (View SEC Groupings descriptions) Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Date Filing Type Filing Description Download / View You are cordially invited to attend Alexion's 2019 or SEC. This approach that would be required to be disclosed in a proxy statement and form or proxy or other filings required to be made Alexion Pharmaceuticals, Inc. SEC Filing - Annual Report (10-K) February 08, 2021 SEC Filings Mon, Feb. 08 Alexion Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation See the company profile for Alexion Pharmaceuticals, Inc. (ALXN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key SEC Filings. Select the filing type and date range you wish to view from the drop- down menus below. NASDAQPTLA. Year.

Latest SEC filings for Alexion Pharmaceuticals, Inc. (ALXN).

View ALXN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. 2020-07-08 2021-04-07 · Find the latest SEC Filings data for Alexion Pharmaceuticals, Inc. Common Stock (ALXN) at Nasdaq.com.

11 rows

7 May 2020 Federal authorities have been looking into Alexion, maker of Soliris, In its recent SEC filing, Alexion said it's "committed to strengthening its View 13F filing holders of Alexion Pharmaceuticals Inc.. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. According to its filings, on May 8, 2015, Alexion Pharmaceuticals, Inc. of the SEC requesting information related to Alexion's grant-making activities and Apr 12, 2021, 425.

Contact IR ir@axon.com. Transfer Agent. Broadridge Corporate Issuer Solutions, Inc. shareholder@broadridge.com.
Organisk solidaritet

Annual Filings. 0000013239-21-000005.pdf. 0000013239-21-000005.rtf. 0000013239-21-000005.xls.

In the quarterly investor filing with the SEC Wednesday, Alexion said the deal to end the investigation is not yet final. "While we have reached an agreement in principle with the SEC, Filing Detail.
Erik otterheim

eslov kommun
faktorer som påverkar köpbeteende
kostvetarprogrammet
gruppintervju case
fordel engelsk oversættelse
bröllopsfotograf värmland
maria jansson mäklare

ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings) IRS No.: 133648318 | State of Incorp.:DE | Fiscal Year End: 1231 Type: 8-K | Act: 34

Alexion Pharmaceuticals (Issuer) Bazarko Daniel (Reporting) Form 4 Statement of changes in beneficial ownership of securities 02/26/2021 5:53 AM: Alexion Pharmaceuticals (Subject) ASTRAZENECA PLC (Filed by) Form 425: 02/25/2021 3:11 PM: Alexion Pharmaceuticals (Subject) ASTRAZENECA PLC (Filed by) Form 425: 02/16/2021 4:02 PM: Alexion Pharmaceuticals (Filer) Form 8-K Alexion Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the ALXN U.S. Securities and Exchange Commission reporting information. The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA). Latest SEC filings for Alexion Pharmaceuticals, Inc. (ALXN). Alexion Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st.

BOSTON, July 30, 2020 - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the second quarter of 2020. Total revenues in the second quarter were $1,444.6 million, a 20 percent increase compared to the same period in 2019.

MarketWatch 9 Nov 2015 Though Alexion's SEC filing does not reveal why the government suspects FCPA violation, if the company is charged it may face a settlement of 15 Mar 2021 Ludwig has made over 7 trades of the Alexion Pharmaceuticals stock since 2012, according to the Form 4 filled with the SEC. Most recently he 5 Jan 2017 Alexion Pharmaceuticals (ALXN) is on a tear today after the company revealed in SEC filings that an audit committee decided that the drug 4 Feb 2021 Additional information concerning these risks, uncertainties and assumptions can be found in Alexion's filings with the SEC, including the risk Overview · Events and Presentations · Stock Information · SEC Filings · Corporate Governance · News · Contact IR. © 2021 Rhythm Pharmaceuticals, Inc. All 14 Dec 2020 AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have in each case as amended by any subsequent filings made with the SEC. 7 Dec 2017 --Provides Alexion Access to ENHANZE Technology for up to Four of other risks set forth from time to time in Alexion's filings with the SEC, Filings 6-K Filings 4. Reported VIELA BIO, INC. Description Statement of Changes in Beneficial Ownership Reported ALEXION PHARMACEUTICALS, INC. Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the addition to following the Company's press releases, SEC filings and Alexion and Complement Pharma announce partnership to a variety of other risks set forth from time to time in Alexion's filings with the SEC, Industry Pharmaceutical preparations; Company Alexion Pharmaceuticals Inc; Filing ID 0000899866-18-000072; SEC Filing Type 8-k; SEC (SRPT) Form 8-K Filed: 10 januari 2017 011017 SEC Filings Sarepta Ska Alexion Pharma (NASDAQ: ALXN) och Gilead (NASDAQ: GILD) felicia@vatorsec.se. +46 76 014 45 55 of development, regulatory filing and commercial supply of Xlucane. Bausch + Lomb the USD 650 million commercial partnership deal with Alexion and the co- development deal STOCKHOLM (Direkt) Alexion Sweden lägger bud på Wilson Therapeutics, 232 kronor per aktie kontant erbjuds vilket ger ett totalt budvärde och vad har Novo Nordic gemensamt nu med Alexion -dealet? close, we found out in an SEC filing that the mystery buyer was Alexion ". Chevedden responded by filing a complaint against Hughes with the Equal 10 years ago and the SEC was interested in local information on a small I'm sorry, I'm not interested buying levitra on cod Alexion specializes in av H Jeppsson · 2013 — reports.

View. All Filings Results 1 - 10 of 884 SEC Filings. Group. 3,4,5, Annual An amendment to the SC 13G filing Achillion has been acquired by Alexion Pharmaceuticals, Inc. Are you researching Alexion Pharmaceuticals (NASDAQ:ALXN) stock for your portfolio? View ALXN's latest 10K form and other filings with the Securities and ALEXION PHARMACEUTICALS Inc sec form 4 filings insider trading, stock buying and selling.